Search results for "SCHEDULE"

showing 10 items of 567 documents

Impact of sociodemographic characteristics on cognitive performance in an elderly Sicilian population.

2002

<i>Objective:</i> To assess cognitive levels in an elderly Sicilian population and to evaluate the role of education and other sociodemographic characteristics in cognitive performance. <i>Background:</i> The pattern of cognitive performance in the elderly has not been investigated extensively in well-defined Italian populations. This study was conducted as part of a door-to-door survey of common neurologic disorders (the Sicilian Neuro-Epidemiologic Study project). <i>Methods:</i> Thirteen physicians administered an Italian version of the Short Portable Mental Status Questionnaire (SPMSQ) to all subjects aged 50 years or older who, on November 1, 1987, r…

GerontologyMaleMental Status ScheduleMultivariate analysisPsychometricsPsychometricsCross-sectional studyEpidemiologyPopulationSociodemographic characteristicDoor-to-door surveyAlzheimer DiseaseRisk FactorsMedicineHumansEffects of sleep deprivation on cognitive performanceeducationSicilyAgedAged 80 and overeducation.field_of_studybusiness.industryCognitionMiddle Agedmedicine.diseaseCognitive impairmentCross-Sectional StudiesSocioeconomic FactorsSicilian Neuro-Epidemiologic Study projectEducational StatusSettore MED/26 - NeurologiaFemaleNeurology (clinical)Alzheimer's diseasebusinessCognition DisordersMental Status ScheduleNeuroepidemiology
researchProduct

A population-based survey of cognitive performance in a Sicilian elderly community.

2010

<i>Background:</i> The global burden of neurodegenerative diseases is increasing. Previous studies reported differences related to age, gender and socioeconomic status. We calculated the cognitive performances of a Sicilian population aged 65 years or older, by means of a door-to-door population-based survey in Bagheria city, Sicily. <i>Methods:</i> A door-to-door survey was carried out in the city of Bagheria, Sicily (prevalence day September 30, 2006). A cohort of 2,200 persons was randomly stratified, obtaining a 25% sample of the whole population. Cognitive function was assessed by Mini Mental State Examination (MMSE). Percentile distributions by age, gender, edu…

GerontologyMalePercentileEpidemiologySurvey population-basedPopulationCohort StudiesCognitionResidence CharacteristicsmedicineDementiaHumanseducationCognitive performanceSocioeconomic statusSicilyAgedAged 80 and overeducation.field_of_studyMini–Mental State Examinationmedicine.diagnostic_testbusiness.industryAge FactorsCognitionRegression analysismedicine.diseaseItalyPopulation SurveillanceCohortFemaleDementiaSettore MED/26 - NeurologiaNeurology (clinical)businessCognition DisordersMental Status Schedule
researchProduct

Everolimus With Reduced Tacrolimus Improves Renal Function in De Novo Liver Transplant Recipients: A Randomized Controlled Trial

2012

    In a prospective, multicenter, open-label study, de novo liver transplant patients were randomized at day 30±5 to (i) everolimus initiation with tacrolimus elimination (TAC Elimination) (ii) everolimus initiation with reduced-exposure tacrolimus (EVR+Reduced TAC) or (iii) standard-exposure tacrolimus (TAC Control). Randomization to TAC Elimination was terminated prematurely due to a higher rate of treated biopsy-proven acute rejection (tBPAR). EVR+Reduced TAC was noninferior to TAC Control for the primary efficacy endpoint (tBPAR, graft loss or death at 12 months posttransplantation): 6.7% versus 9.7% (-3.0%; 95% CI -8.7, 2.6%; p<0.001 for noninferiority [12% margin]). tBPAR occurred in…

Graft RejectionCHRONIC KIDNEY-DISEASEMaleTime Factorsmedicine.medical_treatmentMedizinKaplan-Meier EstimateLiver transplantationKidneyKidney Function TestsGLOMERULAR-FILTRATION-RATEImmunosuppressive AgentHEPATOCELLULAR-CARCINOMASIROLIMUS-BASED IMMUNOSUPPRESSIONImmunology and AllergySirolimuPharmacology (medical)Prospective StudiestacrolimusMYCOPHENOLATE-MOFETILCOMPLICATIONSCross-Over Studiesliver transplantationwithdrawalGraft SurvivalCross-Over StudieMiddle AgedTreatment Outcomesurgical procedures operativeSurvival AnalysireducedLife Sciences & BiomedicineImmunosuppressive AgentsHumanGlomerular Filtration Ratemedicine.drugAdultmedicine.medical_specialtyRandomizationTime FactorAdolescentEfficacyUrologyRenal functionchemical and pharmacologic phenomenaCALCINEURIN INHIBITORRisk AssessmentDrug Administration ScheduleFollow-Up StudieYoung Adultstomatognathic systemTransplantation ImmunologyDOSE TACROLIMUSConfidence IntervalsmedicineHumansMETAANALYSISAgedSirolimusTransplantationKidney Function TestScience & TechnologyEverolimusDose-Response Relationship Drugbusiness.industryeverolimutacrolimuOriginal ArticleseverolimusSurvival AnalysisCrossover studyTacrolimusSurgeryTransplantationProspective StudieCONVERSIONstomatognathic diseasesSirolimusSurgerybusinessConfidence IntervalLiver FailureFollow-Up StudiesAmerican Journal of Transplantation
researchProduct

Retreatment with interferon plus ribavirin of chronic hepatitis C non-responders to interferon monotherapy: a meta-analysis of individual patient dat…

2002

Background and aims: Retreatment with a combination of α interferon (IFN) plus ribavirin of patients with chronic hepatitis C who did not respond to IFN monotherapy has not been assessed in large controlled studies. Methods: To assess the effectiveness and tolerability of IFN/ribavirin retreatment of non-responders to IFN and to identify predictors of complete (biochemical and virological) sustained response, we performed a meta-analysis of individual data on 581 patients from 10 centres. Retreatment with various IFN schedules (mean total dose 544 mega units) and a fixed ribavirin dose (1000–1200 mg/daily depending on body weight) was given for 24–60 (mean 39.5) weeks. Results: Biochemical …

HCV interferon ribavirinAdultMalemedicine.medical_specialtyCombination therapymedicine.medical_treatmentAlpha interferonGastroenterologyAntiviral AgentsDrug Administration Schedulechemistry.chemical_compoundDrug TherapyInternal medicineRibavirinmedicineHumansImmunologic FactorsTreatment FailureChronicAdverse effectChemotherapyAdult; Antiviral Agents; Chi-Square Distribution; Drug Administration Schedule; Drug Therapy; Combination; Female; Hepatitis C; Chronic; Humans; Immunologic Factors; Interferon-alpha; Logistic Models; Male; Middle Aged; Ribavirin; Treatment Failure; gamma-GlutamyltransferaseChi-Square Distributionbusiness.industryRibavirinLiver DiseaseGastroenterologyInterferon-alphaHepatitis Cgamma-GlutamyltransferaseHepatitis C ChronicMiddle Agedmedicine.diseaseHepatitis CConfidence intervalhumanitiesSurgeryLogistic ModelschemistryTolerabilityCombinationDrug Therapy CombinationFemalebusiness
researchProduct

Factors Associated with HPV Vaccine Refusal among Young Adult Women after Ten Years of Vaccine Implementation

2018

In Italy, the Human Papillomavirus (HPV) vaccination was implemented for twelve years old girls in 2007, but its coverage was lower than the recommended level. Sicily is one of the Italian administrative regions with lower vaccination coverage, with a value of 59% for those born in 1996 increasing to 62% coverage for those born in 1999. The aim of the study was to investigate factors associated with the refusal of HPV vaccination among young adult women of Palermo, Italy. The study was approved by the Ethics Committee of the Policlinico &ldquo;Paolo Giaccone&rdquo; Hospital (Palermo 1) and the questionnaire was validated in a convenience sample representing 10% of the young women. A cross-s…

Health Knowledge Attitudes PracticeVaccination scheduleHealth Toxicology and Mutagenesislcsh:MedicineSettore MED/42 - Igiene Generale E Applicata0302 clinical medicineVaccination RefusalSurveys and QuestionnairesHealth belief model030212 general & internal medicineYoung adulthuman papillomavirusResponse rate (survey)education.field_of_study030219 obstetrics & reproductive medicineVaccinationHPV infectionVaccinationItalyFemalewomencatch upAdultmedicine.medical_specialtyAdolescenthuman papillomavirus; vaccine refusal; hesitancy; women; school based; Health Belief Model; gynaecologist; general practitioner; survey; catch upPopulationArticleYoung Adult03 medical and health sciencesschool basedmedicineHumanssurveyPapillomavirus Vaccineseducationbusiness.industryPublic healthPapillomavirus Infectionslcsh:RPublic Health Environmental and Occupational Healthmedicine.diseasegynaecologistCross-Sectional StudiesHuman papillomaviruFamily medicinegeneral practitionervaccine refusalhesitancybusinessCatch up; General practitioner; Gynaecologist; Health Belief Model; Hesitancy; Human papillomavirus; School based; Survey; Vaccine refusal; Women; Public Health Environmental and Occupational Health; Health Toxicology and MutagenesisHealth Belief ModelInternational Journal of Environmental Research and Public Health; Volume 15; Issue 4; Pages: 770
researchProduct

Circulating diphtheria antitoxin levels in children aged 11-14 years in relation to the vaccinal history.

1991

Diphtheria antitoxin level in serum samples obtained from 204 healthy children aged 11-14 years was determined by means of an indirect haemagglutination technique and related to the vaccinal history of the subjects. Irrespective of the time since the last toxoid inoculation, the mean antitoxin titre per ml of serum in the individuals who had received incomplete/irregular anti-diphtheria vaccination in childhood was significantly higher when the number of toxoid doses was higher (from two to more than four doses); the same was not observed for individuals given primary vaccination (three toxoid doses) according to the schedule for childhood vaccination in Italy (regular vaccinees) and one or…

HemagglutinationAdolescentDiphtheria ToxoidPhysiologycomplex mixturesSerologyMedicineHumansChildSicilyImmunization ScheduleGeneral VeterinaryGeneral Immunology and Microbiologybiologybusiness.industryDiphtheriaVaccinationPublic Health Environmental and Occupational HealthToxoidHemagglutination Testsmedicine.diseasebiology.organism_classificationDiphtheria AntitoxinVaccinationTiterInfectious DiseasesTasaImmunologyMolecular MedicineAntitoxinbusinessVaccine
researchProduct

Near-fatal asthma phenotype in the ENFUMOSA Cohort.

2007

Summary Background Near-fatal asthma (NFA) is characterized by severe asthma attacks usually requiring intensive care unit admission. This phenotype of asthma has been studied mainly in acute conditions. Methods The aim of our study was to compare the clinical, functional and inflammatory characteristics of NFA patients with mild to severe asthmatics in stable conditions. We recruited 155 asthmatic patients from five centres of the European Network for Understanding Mechanisms of Severe Asthma: 67 patients with mild-to-moderate asthma controlled by low/medium doses of inhaled corticosteroids; 64 with severe asthma that, despite treatment with high doses of inhaled corticosteroids, long-acti…

Hypersensitivity ImmediateMaleAllergyVital CapacityAnti-asthmatic AgentSeverity of Illness Indexlaw.inventionCohort StudiesLeukocyte CountlawRisk FactorsForced Expiratory Volumenear-fatal asthmaImmunology and AllergyMedicineAnti-Asthmatic AgentsMiddle AgedIntensive care unitInflammation near-fatal asthma severe asthma sputumPhenotypeFemalemedicine.symptomCohort studyAdultinflammation; near-fatal asthma; severe asthma; sputumsevere asthmamedicine.medical_specialtyPartial PressureImmunologyStatus AsthmaticusDrug Administration ScheduleInternal medicineSeverity of illnessHumansRisk factorGlucocorticoidsAsthmaSkin TestsInflammationbusiness.industrysputummedicine.diseaseAsthmarespiratory tract diseasesOxygeninflammationImmunologySputumPatient Compliancebusiness
researchProduct

Cultural adaptation of the Smiling is Fun program for the treatment of depression in the Ecuadorian public health care system: A study protocol for a…

2021

Background Depression is one of the world's major health problems. Due to its high prevalence, it constitutes the first cause of disability among the Americas, where only a very low percentage of the population receives the adequate evidence-based psychological treatment. Internet-Based Interventions (IBIs) are a great alternative to reduce the treatment gap for mental disorders. Although there are several studies in low-and middle-income countries proving IBIs' feasibility and acceptability, there is still little evidence of the effectiveness in diverse social and cultural contexts such as Latin America. Methods Two studies will be described: Study 1 is focused on the cultural adaptation o…

ICD-10 International Classification of Diseases-10GerontologyRCT Randomized Control Trial050103 clinical psychologyOASIS Overall Anxiety Severity and Impairment ScalePsychological interventionAPOI Attitudes Towards Psychological Online Interventionslaw.inventionCultural adaptation0302 clinical medicineCEQ Credibility and Expectancy QuestionnaireRandomized controlled trialODSIS Overall Depression Severity and Impairment Scalelaw030212 general & internal medicineCSQ Client Satisfaction QuestionnaireDepression (differential diagnoses)CRQ Cultural Relevance Questionnaireeducation.field_of_studylcsh:T58.5-58.64Depressionlcsh:Information technology05 social sciencesIBIs Internet-Based InterventionsTiC-P Trimbos/iMTA Questionnaire on Costs on Psychiatric IllnessesSPIRIT Recommendations for Interventional TrialsM.I.N.I. 5.0 MINI International Neuropsychiatric Interview 5.0PC Primary CareQALYs Quality-Adjusted Life-YearsdepressionRandomized Controlled TrialAnxietyRCI Reliable Change Indexmedicine.symptomPsychologyPHQ-9 Patient Health Questionnaire-9WL Waiting Listlcsh:BF1-990PopulationHealth InformaticsContext (language use)cultural adaptationGAD-7 Generalized Anxiety Disorder-703 medical and health sciencesPHC Public Health CareQuality of life (healthcare)EBPTs Evidence-Based Psychological TreatmentsIntervention (counseling)medicine0501 psychology and cognitive sciencesBDI-II Beck Depression Inventory-IIAQoL-6D Assessment of Quality of Life 6 DimensionsMCAR Missing Completely at Randompublic health careeducationPublic Health CareInternet-based interventionFull length ArticleSUS System Usability ScaleLatin Americalcsh:PsychologyWAI-TECH-SF Working Alliance Inventory for Online Intervention-Short Formrandomized controlled trialICERs Incremental Cost-Effectiveness RatiosPANAS Positive and Negative Affect ScheduleE-SF Ecuadorian Cultural Version of Smiling is FunCONSORT Consolidated Standards of Reporting TrialsInternet Interventions
researchProduct

Nurse Scheduling Problem: An Integer Programming Model with a Practical Application

2012

We use a binary integer programming model to formulate and solve a nurse scheduling problem (NSP) which maximally satisfies nurse preferences. In a practical application of a VA hospital, besides considering the scheduling of two types of nurses (registered nurses and licensed practical nurses), two other types of employees (nursing assistants and health care techs), one nurse manager, and a clinical nurse leader are also included in our model. Most of these employees are working full-time. In addition, we distinguish the schedule of weekdays and weekends with different requirements and different preferences for employees. Besides the requirements for each shift, we consider requirements fo…

InformationSystems_GENERALScheduleInteger programming modelComputer scienceNurse scheduling problembusiness.industryHealth careOperations managementPractical nursesbusinessInteger programmingVacation TimeScheduling (computing)
researchProduct

A phase-II study of low-dose cyclophosphamide and recombinant human interleukin-2 in metastatic renal cell carcinoma and malignant melanoma.

1989

Recent preclinical and clinical studies that have demonstrated antitumor activity of high-dose recombinant interleukin-2 (rIL-2), and animal models that demonstrated a synergistic effect of low-dose cyclophosphamide, led us to study rIL-2 (Cetus Corp., Emeryville, Calif) in a phase II clinical trial in combination with low-dose cyclophosphamide in 32 patients, 18 with malignant melanoma and 14 with renal cell carcinoma. rIL-2 was given once daily at 3 x 10(6) U/m2, as a 30-min infusion for 14 days in cycle I and for 2 x 5 days in cycles II and III respectively; if tolerated, the dose was increased to a maximum of 6 x 10(6) U m-2 day-1; the cycles, separated by 1 week treatment-free interval…

Interleukin 2AdultMaleCancer Researchmedicine.medical_specialtyPathologyCyclophosphamidemedicine.medical_treatmentImmunologyPhases of clinical researchGastroenterologyDrug Administration ScheduleRenal cell carcinomaInternal medicineAntineoplastic Combined Chemotherapy ProtocolsImmunology and AllergyMedicineHumansNeoplasm MetastasisCyclophosphamideMelanomaAgedChemotherapyKidneybusiness.industryMelanomaCarcinomaRemission InductionReceptors Interleukin-2Middle Agedmedicine.diseaseKidney NeoplasmsRecombinant ProteinsBlood Cell Countmedicine.anatomical_structurePhenotypeOncologyDrug EvaluationInterleukin-2FemaleBolus (digestion)businessmedicine.drugCancer immunology, immunotherapy : CII
researchProduct